CCRIX
Price
$28.48
Change
-$0.26 (-0.90%)
Updated
Sep 12 closing price
Net Assets
2.64B
VEXPX
Price
$120.50
Change
-$1.43 (-1.17%)
Updated
Sep 12 closing price
Net Assets
20.46B
Interact to see
Advertisement

CCRIX vs VEXPX

Header iconCCRIX vs VEXPX Comparison
Open Charts CCRIX vs VEXPXBanner chart's image
Columbia Small Cap Growth R
Price$28.48
Change-$0.26 (-0.90%)
VolumeN/A
Net Assets2.64B
Vanguard Explorer I
Price$120.50
Change-$1.43 (-1.17%)
VolumeN/A
Net Assets20.46B
CCRIX vs VEXPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CCRIX vs. VEXPX commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCRIX is a Hold and VEXPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 20.5B vs. CCRIX (2.64B). VEXPX pays higher dividends than CCRIX: VEXPX (0.39) vs CCRIX (0.00). CCRIX was incepted earlier than VEXPX: CCRIX (15 years) vs VEXPX (58 years). CCRIX (1.50) is less costly to investors than VEXPX (0.44). CCRIX is a more actively managed with annual turnover of: 146.00 vs. VEXPX (35.00). CCRIX has a lower initial minimum investment than VEXPX: CCRIX (0) vs VEXPX (3000). CCRIX annual gain was more profitable for investors over the last year : 26.83 vs. VEXPX (3.54). CCRIX return over 5 years is better than : 23.93 vs. VEXPX (15.79).
CCRIXVEXPXCCRIX / VEXPX
Total Expense Ratio1.490.44339%
Annual Report Gross Expense Ratio1.500.44341%
Fund Existence15 years58 years-
Gain YTD16.0276.072264%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B20.5B13%
Annual Yield % from dividends0.000.39-
Returns for 1 year26.833.54758%
Returns for 3 years67.8720.46332%
Returns for 5 years23.9315.79152%
Returns for 10 years5.0432.9415%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX14.36N/A
N/A
GMO US Equity III
BGGSX31.46N/A
N/A
Baillie Gifford US Equity Growth I
VPRAX26.63N/A
N/A
VY® T. Rowe Price Capital Apprec R6
AWSSX17.95N/A
N/A
Invesco Global Core Equity R6
MVISX52.31N/A
N/A
Patient Opportunity IS